Stock listing

AIM Stock Price, News, Filings & Events — Aim Immunotech Inc.

Selected listing: AIM · BOATS · USD · US

This page tracks Aim Immunotech Inc.'s AIM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AIM:BOATS. AIM:BOATS is the stock-level entry point for investors researching Aim Immunotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aim Immunotech Inc. is a public company traded under the ticker AIM in the American market. With a market capitalization of approximately $6.9 million, the company is focused on developing innovative immunotherapy solutions. Aim Immunotech is committed to advancing its research and product offerings in the biotechnology sector.

AIM:BOATSUSDUSUpdated September 12, 2026
Aim Immunotech Inc. logo
Ticker
AIM:BOATS
Asset type
Stock
Market cap
$6.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Aim Immunotech Inc. AIM:BOATS stock context

This page tracks Aim Immunotech Inc.'s AIM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AIM:BOATS. AIM:BOATS is the stock-level entry point for investors researching Aim Immunotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Aim Immunotech Inc. is a public company traded under the ticker AIM in the American market. With a market capitalization of approximately $6.9 million, the company is focused on developing innovative immunotherapy solutions. Aim Immunotech is committed to advancing its research and product offerings in the biotechnology sector.

Latest news from Aim Immunotech Inc.

All Aim Immunotech Inc. news →

Aim Immunotech Inc. earnings calls

Research Aim Immunotech Inc.

Alternate listings